The Company

Lost Money on Ventyx Biosciences, Inc. (VTYX)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

Retrieved on: 
Thursday, March 21, 2024
The Company, Psoriasis, Telephone, LLP, CLASS, NEXT, COST, Court, Cryptocurrency

NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ventyx investors who were adversely affected by alleged securities fraud between October 21, 2021 and November 6, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    VTYX investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Levi & Korsinsky Notifies Shareholders of Innodata Inc. (INOD) of a Class Action Lawsuit and an Upcoming Deadline

Retrieved on: 
Thursday, March 21, 2024
The Company, Growth, Telephone, Research, LLP, AI, CLASS, Silicon, Goldengate, NEXT, COST, Court, Cryptocurrency

NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Innodata Inc. ("Innodata" or the "Company") (NASDAQ: INOD) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Innodata Inc. ("Innodata" or the "Company") (NASDAQ: INOD) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Innodata investors who were adversely affected by alleged securities fraud between May 9, 2019 and February 14, 2024.
  • WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

iRobot Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 7, 2024 to Discuss Your Rights – IRBT

Retrieved on: 
Thursday, March 21, 2024
The Company, Telephone, LLP, IRBT, CLASS, IRobot, NEXT, COST, Court, Cryptocurrency

NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in iRobot Corporation ("iRobot" or the "Company") (NASDAQ: IRBT) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in iRobot Corporation ("iRobot" or the "Company") (NASDAQ: IRBT) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of iRobot investors who were adversely affected by alleged securities fraud between August 5, 2022 and January 26, 2024.
  • Follow the link below to get more information and be contacted by a member of our team:
    IRBT investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2024 in Evolution AB Lawsuit – EVVTY

Retrieved on: 
Thursday, March 21, 2024
The Company, Telephone, LLP, Evolution, CLASS, OTC, NEXT, COST, Court

NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Evolution AB (publ) ("Evolution AB" or the "Company") (OTC Other: EVVTY) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Evolution AB (publ) ("Evolution AB" or the "Company") (OTC Other: EVVTY) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Evolution AB investors who were adversely affected by alleged securities fraud.
  • This lawsuit is on behalf of investors who purchased American Depositary Shares of Evolution AB between February 14, 2019 and October 25, 2023, both dates inclusive.
  • If you suffered a loss in Evolution AB during the relevant time frame, you have until March 25, 2024 to request that the Court appoint you as lead plaintiff.

HEALWELL AI Provides Corporate Update and Preliminary Financial Results for the Year Ended December 31, 2023

Retrieved on: 
Thursday, March 21, 2024
The Company, Software as a service, Data science, Partnership, Health, Acquisition, WELL, Bank statement, TSX, EHR, WELL Health Technologies, Hand, AIDX, Medical device

HEALWELL AI to hold a conference call and simultaneous webcast next week, details will be provided separately when they are available.

Key Points: 
  • HEALWELL AI to hold a conference call and simultaneous webcast next week, details will be provided separately when they are available.
  • TORONTO, March 21, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. ("HEALWELL" or the "Company") (TSX: AIDX) (OTCQX: HWAIF), an AI and data science company focused on preventative care, is pleased to provide a corporate update including the release of preliminary financial results for its Fiscal Fourth Quarter and Year Ended December 31, 2023.
  • Selected unaudited financial result expectations for the periods include:
    Annual revenue from continuing operations of $7.32 million during fiscal 2023.
  • HEALWELL will release its financial results for the Year Ended December 31, 2023 next week.

Attention Enfusion, Inc. Investors: Company Investigated by the Portnoy Law Firm

Retrieved on: 
Wednesday, March 20, 2024
Humboldt Hill, California, CSO, The Company, Software as a service, News, CFO

LOS ANGELES, March 20, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Enfusion, Inc. ("Enfusion" or the "Company") (NYSE: ENFN) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Enfusion stock. Enfusion investors are encouraged to contact the firm to discuss their legal rights.

Key Points: 
  • LOS ANGELES, March 20, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Enfusion, Inc. ("Enfusion" or the "Company") (NYSE: ENFN) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Enfusion stock.
  • Enfusion investors are encouraged to contact the firm to discuss their legal rights.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing.

Stallion Uranium Provides Corporate Update

Retrieved on: 
Wednesday, March 20, 2024
Uranium, National Instrument 43-101, Appaloosa, The Company, Beaverlodge, National instrument, Stallion, STUD, Probability

VANCOUVER, British Columbia, March 20, 2024 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the "Company" or "Stallion") (TSX-V: STUD; OTCQB: STLNF; FSE: HM40) is pleased to provide a corporate update on Stallion’s current exploration efforts.

Key Points: 
  • VANCOUVER, British Columbia, March 20, 2024 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the "Company" or "Stallion") (TSX-V: STUD; OTCQB: STLNF; FSE: HM40) is pleased to provide a corporate update on Stallion’s current exploration efforts.
  • Stallion has planned 3 holes totaling 3,300m utilizing a diamond core drill to test for uranium mineralization on it’s 100% owned Appaloosa target.
  • Stallion completed the largest single airborne geophysical survey in the southwestern Athabasca basin, as announced on February 22nd.
  • The foregoing scientific and technical disclosures for Stallion Uranium have been reviewed by Darren Slugoski, P.Geo., VP Exploration, a registered member of the Professional Engineers and Geoscientists of Saskatchewan.

SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results

Retrieved on: 
Wednesday, March 20, 2024
FDA, The Company, Telephone, Q4, EDEN

EDEN PRAIRIE, MN, March 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, March 22, 2024, at 8:30 AM (ET) to present the Q4 and FY2023 financial results

Key Points: 
  • EDEN PRAIRIE, MN, March 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, March 22, 2024, at 8:30 AM (ET) to present the Q4 and FY2023 financial results
    Telephone access to the call will be available by dialing the following numbers:
    OR click the link for instant telephone access to the event.

HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results

Retrieved on: 
Tuesday, March 19, 2024
Tax, The Company, Growth, Conduent, HealthEquity, Acquisition, Table, Nature, HQY, Investment, Depreciation, GAAP, HSA, Eastern Time Zone, Hand, Bank

DRAPER, Utah, March 19, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced financial results for its fourth quarter and fiscal year ended January 31, 2024.

Key Points: 
  • DRAPER, Utah, March 19, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced financial results for its fourth quarter and fiscal year ended January 31, 2024.
  • Revenue for the fourth quarter ended January 31, 2024 was $262.4 million, an increase of 12% compared to $233.8 million for the fourth quarter ended January 31, 2023.
  • Adjusted EBITDA was $98.8 million for the fourth quarter ended January 31, 2024, an increase of 34% compared to $73.6 million for the fourth quarter ended January 31, 2023.
  • HealthEquity management will host a conference call at 4:30 pm (Eastern Time) on Tuesday, March 19, 2024 to discuss the fiscal 2024 fourth quarter and year-end results.

Attention Fair Isaac Corporation Investors: Company Investigated by the Portnoy Law Firm

Retrieved on: 
Monday, March 18, 2024
The Company, FICO, Justice, Communication

LOS ANGELES, March 18, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fair Isaac Corporation ("FICO" or the "Company") (NYSE:FICO) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Fair Isaac stock. Fair Isaac investors are encouraged to contact the firm to discuss their legal rights.

Key Points: 
  • LOS ANGELES, March 18, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fair Isaac Corporation ("FICO" or the "Company") (NYSE:FICO) investors that the law firm has initiated an investigation on behalf of investors that lost money on their Fair Isaac stock.
  • Fair Isaac investors are encouraged to contact the firm to discuss their legal rights.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing.